Outcomes of second-line chemotherapy in patients with relapsed extensive small cell lung cancer

Journal of Thoracic Oncology

Volumn 3, Issue 2, 2008, Pages 163-169

  Froeschl, Sandra ^a   Nicholas, Garth ^a   Gallant, Victor ^a   Laurie, Scott A ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Chemotherapy; Small cell lung cancer; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; TOPOTECAN; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RELAPSE; CANCER SURVIVAL; CHEMOSENSITIVITY; FEMALE; HEALTH STATUS; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 40049094660     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318160c0cb     Document Type: Article

References (21)

1. S Navada P Lai AG Schwartz GP Kalemkerian Temporal trends in small cell lung cancer: analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database J Clin Oncol 24 18 Suppl 2006 abstract 7082.
2. C Collins CS Higano RB Livingston Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study Cancer Chemother Pharmacol 24 1989 128 132
3. WK Evans FA Shepherd R Feld 1985. VP-16 and cisplatin as first-line therapy for small-cell lung cancer J Clin Oncol 3 1985 1471 1477
4. N Hanna PA Bunn Jr C Langer Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer J Clin Oncol 24 2006 2038 2043
5. D Mavroudis E Papadakis M Veslemes A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer Ann Oncol 12 2001 463 470
6. JH Schiller S Adak D Cella Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593—a phase III trial of the Eastern Cooperative Oncology Group J Clin Oncol 19 2001 2114 2122
7. Y Agra M Pelayo M Sacristan Chemotherapy versus best supportive care for extensive small cell lung cancer Cochrane Database Syst Rev 4 2003 CD001990
8. A Kurup N Hanna Treatment of small cell lung cancer Crit Rev Oncol/Hematol 52 2004 117 126
9. SA Laurie D Logan BR Markman Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer Lung Cancer 43 2004 223 240
10. M Vincent B Evans I Smith First-line chemotherapy rechallenge after relapse in small-cell lung cancer Cancer Chemother Pharmacol 21 1988 45 48
11. PE Postmus HH Berendsen N van Zandwijk Retreatment with the induction regimen in small cell lung cancer relapsing after initial response to short term chemotherapy Eur J Cancer Clin Oncol 23 1987 1409 1411
12. J von Powel JH Schiller FA Shepherd Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer J Clin Oncol 17 1999 658 667
13. 2 test of goodness of fit Biometrika 9 1922 186 191
14. E Kaplan P Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
15. N Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
16. DR Cox Regression models and life tables J R Stat Soc B 34 1972 181 220
17. S Cheng WK Evans D Stys-Norman Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline J Thorac Oncol 2 2007 348 354
18. KS Albain J Crowley L Hutchins Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease database Cancer 72 1993 1184 1191
19. SG Spiro RL Souhami DM Geddess Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial Br J Cancer 59 1989 587 593
20. MER O'Brien T-E Ciuleanu H Tsekov Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer J Clin Oncol 24 2006 5441 5447
21. WK De Jong NHT Ten Hacken HJM Groen Third-line chemotherapy for small cell lung cancer Lung Cancer 52 2006 339 342